The hybrid preclinical ecosystem: a strategic roadmap for oncology R&D
Clicks: 3
ID: 315610
2026
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
0.6
/100
3 views
2 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #279 of 335 articles by views in JNCI Journal of the National Cancer Institute
Most read
Least read
Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 335 in total.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Regulatory shifts, economic pressures, and pandemic-related logistical disruptions have challenged the long-standing primacy of animal models in biomedical research. In oncology, the traditional "animal-first" paradigm is increasingly difficult to defend as advances in human-derived systems-including tumor organoids, microphysiological systems, and computational models-now enable the study of specific aspects of tumor biology in experimentally controlled and human-relevant contexts. Consequently, the conceptual architecture of preclinical research is being reorganized; rather than suggesting a replacement of animal models, these changes point to a gradual reconfiguration of how different model systems are positioned within the translational pipeline. This shift necessitates a fundamental reassessment of how experimental design translates into clinical relevance. A strategic roadmap for this hybrid ecosystem illustrates how the integration of human-specific data and refined animal validation can de-risk clinical translation in oncology.
| Reference Key |
openalex_W7163129729
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Wonbeak Yoo |
| Journal | JNCI Journal of the National Cancer Institute |
| Year | 2026 |
| DOI |
10.1093/jnci/djag173
|
| URL | |
| Keywords | Keywords not found |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.